FindTrial
Sign In

Expression of NLRX1, TRAF6 and NFkB in human gastric carcinoma and their relationship with clinicopathological characteristics

Expression of NLRX1, TRAF6 and NFkB in human gastric carcinoma and their relationship with clinicopathological characteristics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020240
Enrollment
Unknown
Registered
2018-12-20
Start date
2018-12-19
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroenterology tumor

Interventions

Case versus control:Nil

Sponsors

THE THIRD PEOPLE'S HOSPITAL OF DALIAN
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From December 2018 to June 2019, gastric cancer tissue specimens were taken from gastric cancer tissues and adjacent normal tissues (5 cm or more from cancer tissues) which were resected by general surgery in the Third People's Hospital of Dalian City.

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
NLRX1;TRAF6;—

Countries

China

Contacts

Public ContactFAN ZHE

THE THIRD PEOPLE'S HOSPITAL OF DALIAN

fanzhe1982@hotmail.com+86 13704289183

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026